Company Email Format Management

Synendos Therapeutics AG

Pharmaceutical Manufacturing Basel, Basel-stadt, Ch 12 employees

Employees: 12
Contacts: 1
Emails: 1

synendos.com LinkedIn Crunchbase

Synendos Therapeutics AG Overview

Headquarters: Basel, Basel-stadt, Ch
Website: synendos.com
Industry: Pharmaceutical Manufacturing
Employees: 12
Founded: 2019
Funding: 26.2M
Company Email: Available in AeroLeads
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

🔹 C Wire

About Synendos Therapeutics AG

Synendos Therapeutics AG is a biopharmaceutical company founded in April 2019 as a spin-off of the University of Bern. Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors were designed and developed at the University of Bern starting from an in silico screening of 12 million compounds which was followed by a thorough med chem programme in collaboration with a CRO. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the brain. Our mission is to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders.

Synendos Therapeutics AG Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Synendos Therapeutics AG Org Chart

Sample employees and titles

Name	Title	Location	Contact
Celine Maeder	Project Leader in Neuroscience and Early Drug Development		View
Andrea Chicca	Co-founder and CEO at Synendos Therapeutics	Zurich, Switzerland	Email
Simon Russell	Co-founder & Chief Commercial Officer at Synendos Therapeutics Ag		View
Isabella Premoli	Translational Medicine - Clinical Science - Biomarkers		View